Regeneron Pharmaceuticals (Q18201): Difference between revisions
Jump to navigation
Jump to search
Created claim: instance of (P2): public company (Q8826) |
Created claim: part of (P7): S&P 500 (Q8884) |
||||||||||||||
| Property / part of | |||||||||||||||
| Property / part of: S&P 500 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / part of: S&P 500 / qualifier | |||||||||||||||
start time: 1 May 2013
| |||||||||||||||
Revision as of 13:15, 3 January 2024
American pharmaceutical company
- Regeneron
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Regeneron Pharmaceuticals |
American pharmaceutical company |
|